Under construction – not a live service
Sign in
Taking people in CanadaNo phase

Studies treatment patterns and costs of lung cancer in Canada

Reviews past health records of adults with lung cancer in Alberta and Ontario.

Plain-language title generated from the registry record
Registry title: LUNG-ROLL: Treatment Patterns and Cost of Illness of Lung Cancer in Canada

Key facts

Where
Calgary and Toronto, CanadaSee the 2 sites

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 130 years old?

Source: NCT07143110, who can take part

Where in Canada

  • CalgaryCalgary, CanadaTaking people
  • TorontoToronto, CanadaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
AstraZeneca
Trial code
NCT07143110
Record updated
3 September 2026
Original description
LUNG-ROLL is a retrospective cohort study that will describe the contemporary treatment patterns, prevalence and incidence, patient demographic and clinical characteristics, clinical outcomes, and healthcare resource use/costs for patients with lung cancer in Canada (specifically, Alberta and Ontario) using administrative data.Read full original descriptionShow less

LUNG-ROLL: Treatment Patterns and Cost of Illness of Lung Cancer in Canada

LUNG-ROLL is a retrospective cohort study that will describe the contemporary treatment patterns, prevalence and incidence, patient demographic and clinical characteristics, clinical outcomes, and healthcare resource use/costs for patients with lung cancer in Canada (specifically, Alberta and Ontario) using administrative data.

Inclusion: Patients with lung cancer between January 1, 2018 and end of the Selection Period; Patient is 18 years of age or older on diagnosis date; Patient has at least 12 months of health insurance coverage prior to the diagnosis date.

Exclusion: Diagnosed with any other cancer in the 5-year period prior to January 1, 2018; Diagnosed with any other cancer concurrently (i.e., on the same date) as lung cancer diagnosis; Invalid or incomplete records for key variables (e.g., missing year of diagnosis, missing cancer type); Non-Ontario or non-Alberta resident on diagnosis date.

ClinicalTrials.gov NCT07143110